{
  "title": "E. Parkinson. Manejo de diskinesia y fluctuaciones motoras",
  "guid": "B6B69679E77D1F0A5BCAB02C",
  "filepath": "/sessions/bold-jolly-cerf/mnt/Dropbox/- Esquemas/- Entidades clínicas/Neurología/UTD. E. Parkinson. Manejo de diskinesia y fluctuaciones motoras-2025-1.smmx",
  "root": {
    "id": "0",
    "parent": "-1",
    "text": "E. Parkinson. Manejo de\ndiskinesia y fluctuaciones motoras",
    "guid": "RrQpHpKJOl70jUIaiTWPGQ",
    "children": [
      {
        "id": "1",
        "parent": "0",
        "text": "I. Introducción",
        "guid": "",
        "children": [
          {
            "id": "2",
            "parent": "1",
            "text": "* Complicaciones levodopa en PD avanzada: Fluctuaciones motoras & diskinesia.",
            "guid": "CN_vuB6kiClR8eLHLq6Adw",
            "children": []
          },
          {
            "id": "3",
            "parent": "1",
            "text": "* Manejo:",
            "guid": "JpCRGtFiQj-0NunmZdMEEA",
            "children": [
              {
                "id": "4",
                "parent": "3",
                "text": "* Farmacológico",
                "guid": "rHnRDPKXXDx7GN4m-EQJyw",
                "children": []
              },
              {
                "id": "5",
                "parent": "3",
                "text": "* Dispositivos",
                "guid": "PFhqegQqdeQI9-G_AYqXlA",
                "children": []
              },
              {
                "id": "6",
                "parent": "3",
                "text": "* Cirugía (DBS, FUS, LCIG, CSAI)",
                "guid": "nLAgvw8COLH9ne-mwncjyQ",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "7",
        "parent": "0",
        "text": "II. Fisiopatología",
        "guid": "",
        "children": [
          {
            "id": "8",
            "parent": "7",
            "text": "* Fluctuaciones\nmotoras:",
            "guid": "qEuqNqA_ogEamtlP8tx0Dg",
            "children": [
              {
                "id": "9",
                "parent": "8",
                "text": "* Degeneración neuronas dopaminérgicas nigroestriatales → ↓almacenamiento/liberación levodopa.",
                "guid": "HLwJ8BlEtG93bGUsZGk4dg",
                "children": []
              },
              {
                "id": "10",
                "parent": "8",
                "text": "* Respuesta levodopa inmediata ~vida media (~90 min).",
                "guid": "ejfYG2vqFQ-_7wdv3NjLpw",
                "children": []
              },
              {
                "id": "11",
                "parent": "8",
                "text": "* Cinética rápida/estimulación pulsátil receptores → ↓ventana terapéutica.",
                "guid": "UIDGeLdxiw4AUy4jG8q8kg",
                "children": []
              },
              {
                "id": "12",
                "parent": "8",
                "text": "* Niveles levodopa: Absorción intestinal (vaciado gástrico, tránsito intestinal, proteínas, SIBO).",
                "guid": "6Sp0D6jWfwWBvsynPNGu2A",
                "children": []
              }
            ]
          },
          {
            "id": "13",
            "parent": "7",
            "text": "* Dyskinesia:",
            "guid": "DpxUx_8FodZR22pPtAQA3w",
            "children": [
              {
                "id": "14",
                "parent": "13",
                "text": "* Sobreexpresión movimiento: Hipersensibilidad receptores dopamina & ↑dopamina.",
                "guid": "hYcW9Nd7IWnFRV7v27J-kg",
                "children": []
              },
              {
                "id": "15",
                "parent": "13",
                "text": "* LID: Por levodopa.",
                "guid": "pSf9yeMqnz6nLJtvKdXRqg",
                "children": []
              },
              {
                "id": "16",
                "parent": "13",
                "text": "* Otros agentes (agonistas dopamina, IMAO-B, ICOMT) → dyskinesia.",
                "guid": "1l2rX2prAUj-o-gMt7aFiQ",
                "children": []
              },
              {
                "id": "17",
                "parent": "13",
                "text": "* Relación levodopa-dyskinesia: Dosis-dependiente, umbral variable.",
                "guid": "xmkRaV5bB85tfk3cMhg8sg",
                "children": []
              },
              {
                "id": "18",
                "parent": "13",
                "text": "* Frecuente en PD inicio temprano (<50 años), - en >80 años.",
                "guid": "2nmmnZXFCLey43xr9X0U8A",
                "children": []
              }
            ]
          },
          {
            "id": "19",
            "parent": "7",
            "text": "* Riesgo complicaciones\nmotoras:",
            "guid": "cmXQ1uC11e2tJ133qD6Bqg",
            "children": [
              {
                "id": "20",
                "parent": "19",
                "text": "* Edad inicio PD ↓, duración ↑, síntomas no motores (ansiedad, depresión) ↑,\ndosis/respuesta levodopa ↑, severidad enfermedad ↑.",
                "guid": "7QPriYf5dUQ9E82281FMYw",
                "children": []
              },
              {
                "id": "21",
                "parent": "19",
                "text": "* Estrategias ahorro levodopa: No afectan historia natural, pueden dañar.",
                "guid": "VGcAOVvlmqo4aJWsuK84sA",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "22",
        "parent": "0",
        "text": "III. Espectro de\nsíntomas en PD",
        "guid": "",
        "children": [
          {
            "id": "23",
            "parent": "22",
            "text": "* Complicaciones\nmotoras:",
            "guid": "MLQFrlZ6oA5FJc96PWkYKw",
            "children": [
              {
                "id": "24",
                "parent": "23",
                "text": "* Frecuentes en PD temprana (30-40% en 5 años),\n+ en PD avanzada (60%+ en 10 años).",
                "guid": "Uis9dRcITPqBFn0jDtA-EQ",
                "children": []
              },
              {
                "id": "25",
                "parent": "23",
                "text": "* PD temprana: Respuesta levodopa suave, sin \"kick-in\" o \"wearing off\".",
                "guid": "p6J1mJffnKYfbpgSe18EWg",
                "children": []
              },
              {
                "id": "26",
                "parent": "23",
                "text": "* PD avanzada: Efecto levodopa <3-4 horas.",
                "guid": "VkdX_2qIffNC-LCQHF8UaQ",
                "children": []
              },
              {
                "id": "27",
                "parent": "23",
                "text": "* \"Complicaciones motoras\": Transición liberación dopamina fisiológica → levodopa exógena.",
                "guid": "USWb3qEWRUUKQVM-US1EWg",
                "children": []
              }
            ]
          },
          {
            "id": "28",
            "parent": "22",
            "text": "* Fluctuaciones\nmotoras:",
            "guid": "W9xtSHcScmL8KCsSMKpH7g",
            "children": [
              {
                "id": "29",
                "parent": "28",
                "text": "* Alteraciones función: \"On\" (respuesta terapéutica) ↔ \"Off\" (sin/↓respuesta).",
                "guid": "ioa4Lry9ahWETbYTJdkbig",
                "children": []
              },
              {
                "id": "30",
                "parent": "28",
                "text": "* \"Wearing off\": Reaparición síntomas PD al final del intervalo de dosis (~3-4h). + Frecuente.",
                "guid": "I-zQzu6ethOL-A3JVuZ4FQ",
                "children": []
              },
              {
                "id": "31",
                "parent": "28",
                "text": "* \"On-off\" (impredecible): Alteraciones súbitas sin relación con dosis.",
                "guid": "d8UG59q1ZiW3OQlU0wDtoQ",
                "children": []
              },
              {
                "id": "32",
                "parent": "28",
                "text": "* Fallo respuesta \"on\": No transición \"off\" → \"on\" tras dosis.",
                "guid": "CMZ3QNewvzKcfW8ZAu9TSA",
                "children": []
              },
              {
                "id": "33",
                "parent": "28",
                "text": "* FOG: Imposibilidad avanzar, inicio, giros, transiciones.\nCon/sin terapia, independiente de fluctuaciones. Síntoma \"off\".",
                "guid": "JvhNKCIuNY_tkwfo7oIOkQ",
                "children": []
              },
              {
                "id": "34",
                "parent": "28",
                "text": "* Akinesia aguda: Exacerbación PD, akinético varios días, no responde a medicación.\n≠ \"off\" dosis-dependiente.",
                "guid": "6f4rmHKOIccKLRnCna_EDw",
                "children": []
              }
            ]
          },
          {
            "id": "35",
            "parent": "22",
            "text": "* Características no motoras: Pueden fluctuar (pánico, confusión).",
            "guid": "DKN9r0oR1T-FC_v3UD_xbQ",
            "children": []
          },
          {
            "id": "36",
            "parent": "22",
            "text": "* Dyskinesia:",
            "guid": "3zMwvN1kYssf9wILZFrTow",
            "children": [
              {
                "id": "37",
                "parent": "36",
                "text": "* LID: Movimientos involuntarios anormales por levodopa.",
                "guid": "vbpOIDWQ1M_depreWHvL_A",
                "children": []
              },
              {
                "id": "38",
                "parent": "36",
                "text": "* Otros agentes (agonistas) → exacerban dyskinesia preexistente.",
                "guid": "9fk144K-0ZiLH22zJkeAeg",
                "children": []
              },
              {
                "id": "39",
                "parent": "36",
                "text": "* Tipos: corea, distonía, atetosis, balismo, mioclonía.",
                "guid": "jwx3NjAVchEm31qppoEE6g",
                "children": []
              },
              {
                "id": "40",
                "parent": "36",
                "text": "* Dyskinesia pico de dosis: \"On\", coreiforme, 30-90 min tras dosis.",
                "guid": "HzeO1K2mj-3LNXfGk-__vQ",
                "children": []
              },
              {
                "id": "41",
                "parent": "36",
                "text": "* Dyskinesia bifásica: 2 periodos movimientos involuntarios tras dosis, \"on\" y \"wearing off\".",
                "guid": "XEAsRb_q3BWt4oOF076trA",
                "children": []
              },
              {
                "id": "42",
                "parent": "36",
                "text": "* Dystonia \"wearing off\": Espasmo muscular \"off\", + frecuente por la mañana.",
                "guid": "oxPImwsOnqGtgGN-ZkO3Gg",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "43",
        "parent": "0",
        "text": "IV. Evaluación de Fluctuaciones\nMotoras y Dyskinesia",
        "guid": "",
        "children": [
          {
            "id": "44",
            "parent": "43",
            "text": "* Evaluación\ngeneral:",
            "guid": "uhfHNXBNLqtL6WQ6p6wP_Q",
            "children": [
              {
                "id": "45",
                "parent": "44",
                "text": "* Evaluar respuesta levodopa y efectos adversos en cada visita\n→ Optimizar respuesta y CdV.",
                "guid": "JhhjougePzsKACh4Dc389A",
                "children": []
              },
              {
                "id": "46",
                "parent": "44",
                "text": "* Revisar terminología, mejorar reconocimiento y reporte complicaciones motoras.",
                "guid": "lfR5H6m7NohIAfMuln4-FQ",
                "children": []
              }
            ]
          },
          {
            "id": "47",
            "parent": "43",
            "text": "* Anamnesis y\nobservación:",
            "guid": "9VUxyipUWpZwYJEftWO4sQ",
            "children": [
              {
                "id": "48",
                "parent": "47",
                "text": "* Diferenciar temblor ↔ dyskinesia (\"shaking\").",
                "guid": "LOdYe4npxT2OSYnw2SmkEA",
                "children": []
              },
              {
                "id": "49",
                "parent": "47",
                "text": "* Anotar hora examen respecto a última dosis levodopa.",
                "guid": "TR2PjvCZNWRPNDDPFmJ5hg",
                "children": []
              },
              {
                "id": "50",
                "parent": "47",
                "text": "* Horario levodopa: Fijo (reloj) ↔ a necesidad (\"wearing off\").",
                "guid": "qQzbLYlRSTS0y_3X3BBBHw",
                "children": []
              },
              {
                "id": "51",
                "parent": "47",
                "text": "* Comida/proteínas: Interfieren absorción levodopa.",
                "guid": "WDF-J0HNyMAvELic8uwBiw",
                "children": []
              },
              {
                "id": "52",
                "parent": "47",
                "text": "* Videos caseros: Útiles en patrones complejos.",
                "guid": "wroKaTXDVMnmGvBb0WeCzg",
                "children": []
              },
              {
                "id": "53",
                "parent": "47",
                "text": "* Telehealth: Captar diferentes estados.",
                "guid": "rrhX4FfP5aR5y_j65V6GlQ",
                "children": []
              },
              {
                "id": "54",
                "parent": "47",
                "text": "* Neurólogos: Test \"off-on\" programado (eval. terapias avanzadas).",
                "guid": "0jw0X1lsKPirGfLe4V8jRQ",
                "children": []
              }
            ]
          },
          {
            "id": "55",
            "parent": "43",
            "text": "* Diarios de\nsíntomas:",
            "guid": "5zmpmWhxGWw97ZCmpCQNHw",
            "children": [
              {
                "id": "56",
                "parent": "55",
                "text": "* Útiles, pero pueden ser no fiables si no se conocen definiciones\n(dyskinesia, temblor, distonía, \"on\"/\"off\").",
                "guid": "P7fNeYtyXWLqTjac35Esiw",
                "children": []
              },
              {
                "id": "57",
                "parent": "55",
                "text": "* Educación y práctica → Diarios + precisos.",
                "guid": "LjoSVD8CFR0OgvZjwHB7QA",
                "children": []
              }
            ]
          },
          {
            "id": "58",
            "parent": "43",
            "text": "* Derivación a\nespecialista:",
            "guid": "zCxzETj2Nr7-AVyWV6m-aQ",
            "children": [
              {
                "id": "59",
                "parent": "58",
                "text": "* Pacientes refractarios con fluctuaciones/dyskinesia problemáticas\n→ Optimizar terapia médica/terapias avanzadas.",
                "guid": "DGXHHV-BpcGnoEX_8FO-Qg",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "60",
        "parent": "0",
        "text": "V. Abordaje del\n\"Wearing Off\" en PD",
        "guid": "",
        "children": [
          {
            "id": "61",
            "parent": "60",
            "text": "* Ajustes dietéticos:",
            "guid": "fJeZS35RroB9mQ8g7UGsRw",
            "children": [
              {
                "id": "62",
                "parent": "61",
                "text": "* Proteínas: Compiten con levodopa → ↓beneficio.",
                "guid": "am6DyMI3-34IYKleJvsdaw",
                "children": []
              },
              {
                "id": "63",
                "parent": "61",
                "text": "* Evitar proteínas con medicación / tomar con estómago vacío\n(30-60 min antes o 60-90 min después).",
                "guid": "gXzLaRAfSEz8LiRwT_8Dyg",
                "children": []
              },
              {
                "id": "64",
                "parent": "61",
                "text": "* Dieta redistribución proteínas (PRD): Mayoría proteínas por la noche.",
                "guid": "BNCIPVflSD0N6EVGrCeUVA",
                "children": []
              },
              {
                "id": "65",
                "parent": "61",
                "text": "* Limitaciones: Efectos 2arios levodopa, inconveniencia, adherencia.",
                "guid": "JoikEOgPZ5jq5MjZmVh50A",
                "children": []
              }
            ]
          },
          {
            "id": "66",
            "parent": "60",
            "text": "* Otras estrategias (exploratorias): Erradicación H. pylori, SIBO.",
            "guid": "cEPrTdygSQHDtJdllNtLnw",
            "children": []
          },
          {
            "id": "67",
            "parent": "60",
            "text": "* Ajuste dosis/intervalo\nlevodopa:",
            "guid": "tLdHqjw2eVZDg8IHg5K_bA",
            "children": [
              {
                "id": "68",
                "parent": "67",
                "text": "* PD leve: ↑dosis levodopa.",
                "guid": "QUOh2JUZ1BlHSMJQ4Jl_fw",
                "children": []
              },
              {
                "id": "69",
                "parent": "67",
                "text": "* PD avanzada: ↓dosis, ↑frecuencia (fraccionamiento).",
                "guid": "7Vaaxhpi6-4wcF_4xZqaKA",
                "children": []
              },
              {
                "id": "70",
                "parent": "67",
                "text": "* Posible: + dosis al final del día, fallo dosis si no se alcanza umbral.",
                "guid": "dPBtcwluXyDjlM34TcfBDw",
                "children": []
              },
              {
                "id": "71",
                "parent": "67",
                "text": "* Fraccionamiento: Con comprimidos estándar.",
                "guid": "qEst1X3meNC8EFwPr-IiXA",
                "children": []
              },
              {
                "id": "72",
                "parent": "67",
                "text": "* Levodopa líquida: No disponible comercialmente, preparación compleja.",
                "guid": "wQLg-Q3BOPKBz--DjujTEw",
                "children": []
              },
              {
                "id": "73",
                "parent": "67",
                "text": "* Respuesta \"frágil\": Dosis sin respuesta /\nrespuesta exagerada con dyskinesia.",
                "guid": "9swj7CLGsiytN1CNMqKxBg",
                "children": []
              }
            ]
          },
          {
            "id": "74",
            "parent": "60",
            "text": "* Formulaciones\nlevodopa oral:",
            "guid": "fZNhn_pme5ZsmsQjyZI9cw",
            "children": [
              {
                "id": "75",
                "parent": "74",
                "text": "* Liberación\ncontrolada (CR):",
                "guid": "EElPmdWp6uTVFh9lqLAZIw",
                "children": [
                  {
                    "id": "76",
                    "parent": "75",
                    "text": "* Útil en PD temprana (sin fluctuaciones).",
                    "guid": "tZ7u7_qjme_OdV8hpmk45g",
                    "children": []
                  },
                  {
                    "id": "77",
                    "parent": "75",
                    "text": "* \"Wearing off\": Uso nocturno, inicio acción impredecible, respuesta retardada.",
                    "guid": "nJlnEyxcY7dHFD7-tsTSjA",
                    "children": []
                  },
                  {
                    "id": "78",
                    "parent": "75",
                    "text": "* No ↓ \"off\" de forma fiable.",
                    "guid": "0VeUwTSK_cWGu8unCTdDRA",
                    "children": []
                  }
                ]
              },
              {
                "id": "79",
                "parent": "74",
                "text": "* Liberación prolongada (ER):\nRytary (Numient), Crexont.",
                "guid": "EsfrwJpNul0vvvFEGYg4Rg",
                "children": [
                  {
                    "id": "80",
                    "parent": "79",
                    "text": "* IR + ER → Inicio rápido, ↓efectos pico, ↑biodisponibilidad, ↑duración.",
                    "guid": "-PBp07SuZ82sljpA22t1ug",
                    "children": []
                  },
                  {
                    "id": "81",
                    "parent": "79",
                    "text": "* Rytary: Perlas IR/ER.",
                    "guid": "p6ZRl17Her1wtmaKpjHocw",
                    "children": []
                  },
                  {
                    "id": "82",
                    "parent": "79",
                    "text": "* Crexont: Gránulos IR + perlas ER\n(↓desintegración estómago, ↑adhesión intestino).",
                    "guid": "uUc4DqoTkN-vdLsO3VpC6g",
                    "children": [
                      {
                        "id": "83",
                        "parent": "82",
                        "text": "* Pico inicial 1h (similar a IR), sostenido 4-5h, \"wearing off\" gradual >6h.",
                        "guid": "SnWEy-MN8jVV1vCLC9dIRw",
                        "children": []
                      },
                      {
                        "id": "84",
                        "parent": "82",
                        "text": "* Cmax < IR → Posible ↑dosis 2x para alcanzar \"on\".",
                        "guid": "xhmWib6Di_gnvVoiTExyBw",
                        "children": []
                      },
                      {
                        "id": "85",
                        "parent": "82",
                        "text": "* Potencial: ↓dyskinesia pico de dosis, ↑\"on\" (sin dyskinesia), ↓síntomas \"off\".",
                        "guid": "JwVPe8wXwUJcRrNfkMCBIQ",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "86",
                    "parent": "79",
                    "text": "* Conversión IR/CR → ER: Gradual, tablas conversión.",
                    "guid": "Nyncm0ZrcDpw1Zj1w3NPNw",
                    "children": []
                  },
                  {
                    "id": "87",
                    "parent": "79",
                    "text": "* Rytary ≠ Crexont (potencia/dosis).",
                    "guid": "o8CgHNwd3Y2EPGmJ9kntgQ",
                    "children": []
                  },
                  {
                    "id": "88",
                    "parent": "79",
                    "text": "* Práctica: ↓nº dosis diarias, ↑fluctuaciones, carga similar/↑, dosis mg diaria ~2x.",
                    "guid": "PgRYwajXAfLNaQLitwUCUg",
                    "children": []
                  },
                  {
                    "id": "89",
                    "parent": "79",
                    "text": "* Costoso, cobertura limitada.",
                    "guid": "FKz2Aewc_RHlelFYamfCZA",
                    "children": []
                  },
                  {
                    "id": "90",
                    "parent": "79",
                    "text": "* Uso nocturno: Reemplazar CR.",
                    "guid": "LKPNvRaynye2CvvoNBiZrg",
                    "children": []
                  },
                  {
                    "id": "91",
                    "parent": "79",
                    "text": "* Apertura cápsulas: Espolvorear sobre comida.",
                    "guid": "b9uFeij5L-4HoUMz3Tu6Zw",
                    "children": []
                  },
                  {
                    "id": "92",
                    "parent": "79",
                    "text": "* Evidencia:",
                    "guid": "koPYA_n7SFxtbaPwYyv-dA",
                    "children": [
                      {
                        "id": "93",
                        "parent": "92",
                        "text": "* Rytary: ADVANCE-PD (↓\"off\" ~70\nmin/día vs. IR), dosis diaria ~2x IR.",
                        "guid": "y7R3JKFZUiIQVFUmIdoK6Q",
                        "children": []
                      },
                      {
                        "id": "94",
                        "parent": "92",
                        "text": "* Crexont: RISE-PD (↑\"on\" bueno 32 min vs.\nIR), dosis cada 6-8h, análisis post-hoc (↑\"on\"\nbueno ~90 min/dosis).",
                        "guid": "MwwZRK7U4te7F7dRV52GHA",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "95",
                "parent": "74",
                "text": "* Terapias\nadjuntas:",
                "guid": "vXxCcwgFJAQPXq9S-WVwNg",
                "children": [
                  {
                    "id": "96",
                    "parent": "95",
                    "text": "* Objetivo: ↓\"off\".",
                    "guid": "B69Za6uSym-Yoef9Et8nKg",
                    "children": []
                  },
                  {
                    "id": "97",
                    "parent": "95",
                    "text": "* Limitación: Dyskinesia, efectos 2arios dopaminérgicos.",
                    "guid": "s5NCvUlELCc_PZ5zlV1hzg",
                    "children": []
                  },
                  {
                    "id": "98",
                    "parent": "95",
                    "text": "* Eficacia similar, selección individualizada.",
                    "guid": "56wiwSE2tRdgHJXMmK5Vow",
                    "children": []
                  },
                  {
                    "id": "99",
                    "parent": "95",
                    "text": "* Agonistas dopamina:",
                    "guid": "Om62hVCFPYPAyDMLNNJCSw",
                    "children": [
                      {
                        "id": "100",
                        "parent": "99",
                        "text": "* Efecto dopaminérgico, mejor función motora, ↑riesgo efectos 2arios (↑en >75 años).",
                        "guid": "jFj-Q85KfBNdUjV0cU2eUA",
                        "children": []
                      },
                      {
                        "id": "101",
                        "parent": "99",
                        "text": "* Inicio: Dosis mínima, titulación cuidadosa.",
                        "guid": "-Gg-KzoU0bXhC9mfEXwkBA",
                        "children": []
                      },
                      {
                        "id": "102",
                        "parent": "99",
                        "text": "* Diferencias mínimas entre agentes.",
                        "guid": "87oSxoNZ6AU-kXQTNIDrhw",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "id": "103",
            "parent": "60",
            "text": "* Inhibidores catecol-O-metiltransferasa (COMT):\nEntacapone, opicapone, tolcapone.",
            "guid": "8WfBdqaX6ahJwSsTT1O83Q",
            "children": [
              {
                "id": "104",
                "parent": "103",
                "text": "* ↑Efecto levodopa, ↓\"off\".",
                "guid": "F2wzmSNt7nTimXd4inFXgQ",
                "children": []
              },
              {
                "id": "105",
                "parent": "103",
                "text": "* Entacapone/opicapone: + Seguros.",
                "guid": "OkCsz4Pe83hBEsUcjk_m4g",
                "children": []
              },
              {
                "id": "106",
                "parent": "103",
                "text": "* Tolcapone: Riesgo hepatotoxicidad.",
                "guid": "yIP3JqLW1gKkyIpcrn8q_g",
                "children": []
              },
              {
                "id": "107",
                "parent": "103",
                "text": "* Añadir ICOMT: ↓dosis levodopa 10-30%.",
                "guid": "GbTjfRMrL8dsBwokqBbaGQ",
                "children": []
              },
              {
                "id": "108",
                "parent": "103",
                "text": "* Entacapone: 200 mg/dosis levodopa, máx 8 dosis al día",
                "guid": "bAhWiI_7yNI8Rvdzqe1LTg",
                "children": []
              },
              {
                "id": "109",
                "parent": "103",
                "text": "Opicapone: 50 mg/día (25 mg en\ndaño hepático moderado).",
                "guid": "C7caxakSDryQnwvJPSFy7Q",
                "children": []
              },
              {
                "id": "110",
                "parent": "103",
                "text": "* Tolcapone: 100 mg 3 veces/día.",
                "guid": "G6MHJcfP5bTWVFQKRTYvmQ",
                "children": []
              },
              {
                "id": "111",
                "parent": "103",
                "text": "* Efectos 2arios: ↑estimulación dopaminérgica.",
                "guid": "nToYTUfnuXvFJsTI3Gsqmg",
                "children": []
              },
              {
                "id": "112",
                "parent": "103",
                "text": "* Orina naranja (entacapone, tolcapone).",
                "guid": "Od9ajPbCviukoMPpCKjrLQ",
                "children": []
              },
              {
                "id": "113",
                "parent": "103",
                "text": "* Diarrea (10%, puede ser grave).",
                "guid": "pcrquB0MEGyGh0QCbmhNvg",
                "children": []
              }
            ]
          },
          {
            "id": "114",
            "parent": "60",
            "text": "* Inhibidores monoaminooxidasa tipo B (MAO-B):\nRasagilina, safinamida, selegilina.",
            "guid": "tUGpszAWNr_f4vnEmLrIbg",
            "children": [
              {
                "id": "115",
                "parent": "114",
                "text": "* ↑Dopamina, ↓\"wearing off\".",
                "guid": "AjchekGvsvG9hoV6jZQMXg",
                "children": []
              },
              {
                "id": "116",
                "parent": "114",
                "text": "* Eficacia similar a ICOMT.",
                "guid": "oAq0TKrZDKKi1eGNLfvzMA",
                "children": []
              },
              {
                "id": "117",
                "parent": "114",
                "text": "* Selectivos MAO-B, ↓riesgo crisis hipertensivas (vs. IMAO no selectivos).",
                "guid": "XNONZusQH2leWsUJGSu27Q",
                "children": []
              },
              {
                "id": "118",
                "parent": "114",
                "text": "* Rasagilina: ↓\"off\" ~1h (LARGO).",
                "guid": "fLfGroGdmbOnquslRM5z1g",
                "children": []
              },
              {
                "id": "119",
                "parent": "114",
                "text": "* Safinamida: ↑\"on\" sin dyskinesia ~1.4h.",
                "guid": "pD-u0vnQAqRH1M3SsazNaQ",
                "children": []
              },
              {
                "id": "120",
                "parent": "114",
                "text": "* Selegilina: Efecto leve, posible selegilina desintegradora oral.",
                "guid": "J7Xmxb3r_a_F_2oU-m5Fuw",
                "children": []
              },
              {
                "id": "121",
                "parent": "114",
                "text": "* Istradefyllina: Antagonista receptor A2A.",
                "guid": "B5BzgyIiy2iNo6TlAu2YFA",
                "children": []
              },
              {
                "id": "122",
                "parent": "114",
                "text": "* ↓\"off\" ~1h.",
                "guid": "CSAD68xj7cEeDTZsKZ2Xvg",
                "children": []
              },
              {
                "id": "123",
                "parent": "114",
                "text": "* Efectos 2arios: Dyskinesia, mareo, estreñimiento, náuseas, alucinaciones, insomnio.",
                "guid": "2-TDmbxtvew7Ppb8k4pp2Q",
                "children": []
              },
              {
                "id": "124",
                "parent": "114",
                "text": "* Dosis: 20 mg/día, máx. 40 mg/día (20 mg en daño hepático moderado).",
                "guid": "oYHMlZX9IPThg_Q-1L5xeA",
                "children": []
              },
              {
                "id": "125",
                "parent": "114",
                "text": "* Metabolización: CYP1A1, CYP3A4.",
                "guid": "SvLAbVwyzMV4b9ia9BrMnQ",
                "children": []
              }
            ]
          },
          {
            "id": "126",
            "parent": "60",
            "text": "* Istradefyllina:",
            "guid": "Jif3oXHHPmpGW-sHRLe78w",
            "children": [
              {
                "id": "127",
                "parent": "126",
                "text": "* Antagonista receptor A2A.",
                "guid": "_KCotVeLosygWOlEbNK-bw",
                "children": []
              },
              {
                "id": "128",
                "parent": "126",
                "text": "* ↓\"off\" ~1h.",
                "guid": "LbwjFOfaJpa3M-A9t6cNVw",
                "children": []
              },
              {
                "id": "129",
                "parent": "126",
                "text": "* Efectos 2arios: Dyskinesia, mareo, estreñimiento, náuseas, alucinaciones, insomnio.",
                "guid": "Lmd9EAgq3G93oGudOFyXig",
                "children": []
              },
              {
                "id": "130",
                "parent": "126",
                "text": "* Dosis: 20 mg/día, máx. 40 mg/día (20 mg en daño hepático moderado).",
                "guid": "WLH5AxpCh5HPH7UwqtMjng",
                "children": []
              },
              {
                "id": "131",
                "parent": "126",
                "text": "* Metabolización: CYP1A1, CYP3A4.",
                "guid": "oQ7yIO-w_CJkkt00Mj7Tmg",
                "children": []
              }
            ]
          },
          {
            "id": "132",
            "parent": "60",
            "text": "* Estrategias rescate\n\"on-demand\":",
            "guid": "B9b9Fa7h6ivVcfeYPFJ3Vg",
            "children": [
              {
                "id": "133",
                "parent": "132",
                "text": "* Para \"off\" repentinos/prolongados.",
                "guid": "BcKnygFfALQIY5aQSXuHWA",
                "children": []
              },
              {
                "id": "134",
                "parent": "132",
                "text": "* Apomorfina:",
                "guid": "knKBb_PMOXAp1yNsPxhuHA",
                "children": [
                  {
                    "id": "135",
                    "parent": "134",
                    "text": "* Inyección SC: \"Off\" repentinos, \"off\"\nmatutinos, puente entre dosis levodopa.",
                    "guid": "J_y_pz3eDPbVRqW9EV10ag",
                    "children": [
                      {
                        "id": "136",
                        "parent": "135",
                        "text": "* Test dosis: Riesgo hipotensión.",
                        "guid": "B8vWz1prqaLNwTt4MVvtRg",
                        "children": []
                      },
                      {
                        "id": "137",
                        "parent": "135",
                        "text": "* Premedicación: Trimetobenzamida (o domperidona).",
                        "guid": "b3m-EMf3Hz-yIF0ZRR6RCw",
                        "children": []
                      },
                      {
                        "id": "138",
                        "parent": "135",
                        "text": "* Dosis: 1-2 mg, ↑1 mg cada 2-4 días, máx. 6 mg/dosis, 3 veces/día, máx. 5/día, 20 mg/día.",
                        "guid": "CNYerIvlVhVOnp1XuP539Q",
                        "children": []
                      },
                      {
                        "id": "139",
                        "parent": "135",
                        "text": "* Efectos 2arios: Nódulos piel, reacciones cutáneas, somnolencia, náuseas, dyskinesia, síntomas neuropsiquiátricos.",
                        "guid": "oivoGk4ucw8UQDsCWVuR5Q",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "140",
                    "parent": "134",
                    "text": "* Infusión SC continua (CSAI):\n↓\"off\", ↑\"on\".",
                    "guid": "79Ah3t3A0_geAxfiOd1W3g",
                    "children": []
                  },
                  {
                    "id": "141",
                    "parent": "134",
                    "text": "* Película sublingual:",
                    "guid": "Fyq_AXT_dC6vfxsYkKCgIQ",
                    "children": [
                      {
                        "id": "142",
                        "parent": "141",
                        "text": "* Absorción oral → ↓metabolismo 1er paso.",
                        "guid": "_KRjDTbPAl25grAgitpl6Q",
                        "children": []
                      },
                      {
                        "id": "143",
                        "parent": "141",
                        "text": "* Efectos 2arios: Orofaríngeos (edema mucosa, boca seca, dolor lengua), náuseas, somnolencia, mareo.",
                        "guid": "RCJ4-UclqvzXgELnFkXdGg",
                        "children": []
                      },
                      {
                        "id": "144",
                        "parent": "141",
                        "text": "* Premedicación: Trimetobenzamida (o domperidona).",
                        "guid": "x5Wpo9MxxZz0xmn6oliweQ",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "145",
                "parent": "132",
                "text": "* Levodopa inhalada:",
                "guid": "MZnCCNuciFnyGJ3P7xtaiw",
                "children": [
                  {
                    "id": "146",
                    "parent": "145",
                    "text": "* Absorción alveolar → ↓variabilidad intestinal/hepática.",
                    "guid": "U7_uroEolbuPuQh-IKlWYw",
                    "children": []
                  },
                  {
                    "id": "147",
                    "parent": "145",
                    "text": "* Pico plasmático ~15 min, mejoría clínica ~5 min.",
                    "guid": "YqF1u5SN-t0Z_1ED0mB7JA",
                    "children": []
                  },
                  {
                    "id": "148",
                    "parent": "145",
                    "text": "* Eficacia: ↑UPDRS 30 min, ↑\"on\" 60 min, no ↓tiempo total \"off\".",
                    "guid": "esUU-u0U9CzqiCBnT1vs6A",
                    "children": []
                  },
                  {
                    "id": "149",
                    "parent": "145",
                    "text": "* Limitaciones: Técnica inhalación, tos, dosis óptima, administración durante \"off\".",
                    "guid": "LrtRpuoSMdVJhAsibCXasQ",
                    "children": []
                  },
                  {
                    "id": "150",
                    "parent": "145",
                    "text": "* Dosis: Máx. 5 veces/día, 84 mg/dosis, 420 mg/día.",
                    "guid": "ZMrPrbIj-OQKclT1IIQwAQ",
                    "children": []
                  },
                  {
                    "id": "151",
                    "parent": "145",
                    "text": "* Efectos 2arios: Tos, infección tracto respiratorio superior, náuseas, esputo decolorado, dyskinesia.",
                    "guid": "C7bOwUinMT8ofCuwewId3g",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "152",
            "parent": "60",
            "text": "* Terapias asistidas por\ndispositivos/quirúrgicas:",
            "guid": "k8GyuQO-hTdhHtXUskneDA",
            "children": [
              {
                "id": "153",
                "parent": "152",
                "text": "* Para fallo terapias médicas.",
                "guid": "pFpBsaUS956GBzICUrMeeA",
                "children": []
              },
              {
                "id": "154",
                "parent": "152",
                "text": "* Opciones: DBS, FUS, LCIG, CSAI,\nCSI-foslevodopa-foscarbidopa.",
                "guid": "Joi0W7owcP6E4Vnl1WKl0w",
                "children": []
              },
              {
                "id": "155",
                "parent": "152",
                "text": "* Indicaciones:",
                "guid": "WrZGJiDPhEUQwF3WYIpR1g",
                "children": [
                  {
                    "id": "156",
                    "parent": "155",
                    "text": "* Fluctuaciones graves a pesar de tx óptimo.",
                    "guid": "DB1bjojSCli-XP1ZJ823RQ",
                    "children": []
                  },
                  {
                    "id": "157",
                    "parent": "155",
                    "text": "* Discapacidad/↓CdV.",
                    "guid": "6d8hzs7RX2IAfaxLvzii-w",
                    "children": []
                  },
                  {
                    "id": "158",
                    "parent": "155",
                    "text": "* Respuesta inconsistente.",
                    "guid": "z9GVWoL3hi2B3KuMfxye3A",
                    "children": []
                  },
                  {
                    "id": "159",
                    "parent": "155",
                    "text": "* Dyskinesia/fluctuaciones que requieren ajuste frecuente sin beneficio.",
                    "guid": "ADfpAcOBTl_GHfoCojPOwA",
                    "children": []
                  },
                  {
                    "id": "160",
                    "parent": "155",
                    "text": "* Levodopa ≥4 veces/día.",
                    "guid": "MK6bm-P1HdUYp0Mwod5HOg",
                    "children": []
                  },
                  {
                    "id": "161",
                    "parent": "155",
                    "text": "* Temblor refractario grave (DBS).",
                    "guid": "_RgxHXUgLl1v8OEu553W3A",
                    "children": []
                  }
                ]
              },
              {
                "id": "162",
                "parent": "152",
                "text": "* Requisito: Respuesta a levodopa (excepto temblor refractario).",
                "guid": "siHFiHaZPnLiRMXGdZvsQQ",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "163",
        "parent": "0",
        "text": "VI. Abordaje de la Dyskinesia\nPico de Dosis en PD",
        "guid": "",
        "children": [
          {
            "id": "164",
            "parent": "163",
            "text": "* Características:",
            "guid": "Jc0yPJcX38xC6sPEJzMopw",
            "children": [
              {
                "id": "165",
                "parent": "164",
                "text": "* LID: Relacionada con dosis levodopa.",
                "guid": "m5QtCC4GiiyI9nzI923kDQ",
                "children": []
              },
              {
                "id": "166",
                "parent": "164",
                "text": "* Inicio: ~30 min tras dosis, pico a los 60 min, ↓ a los 90 min.",
                "guid": "D1q12cP1x3FJ-QoOj9YryQ",
                "children": []
              },
              {
                "id": "167",
                "parent": "164",
                "text": "* Dosis-dependiente, predecible, reversible.",
                "guid": "mFKoOY6vdqN8jb6qt17iXQ",
                "children": []
              },
              {
                "id": "168",
                "parent": "164",
                "text": "* Pacientes jóvenes (<50 años): + propensos a dyskinesia.",
                "guid": "DmH6iI4tsKOxtk8xBOkNXA",
                "children": []
              }
            ]
          },
          {
            "id": "169",
            "parent": "163",
            "text": "* Tx 1ª línea: ↓dosis levodopa, ↓terapias dopaminérgicas adjuntas, amantadina/clozapina.",
            "guid": "2nj2MmtIHDVopQb3-Tysjw",
            "children": []
          },
          {
            "id": "170",
            "parent": "163",
            "text": "* ¿Cuándo tratar?",
            "guid": "vyUxbPL8mcS6pLoQ2pyhAQ",
            "children": [
              {
                "id": "171",
                "parent": "170",
                "text": "* No toda dyskinesia requiere tx.",
                "guid": "Kg9bhspLDBXThi95OPvbrA",
                "children": []
              },
              {
                "id": "172",
                "parent": "170",
                "text": "* Dyskinesia problemática: Movimientos balísticos,\ninterfieren con coordinación/función/equilibrio.",
                "guid": "P8nJ4fVlToyyEKQJ-y5ehA",
                "children": []
              }
            ]
          },
          {
            "id": "173",
            "parent": "163",
            "text": "* Reducción\nlevodopa/terapias\nadjuntas:",
            "guid": "95EuojJ0qrT_tOYU_T9Qow",
            "children": [
              {
                "id": "174",
                "parent": "173",
                "text": "* PD temprana: ↓dosis levodopa.",
                "guid": "JK3cjVOC-EFPG7Eav-aS3A",
                "children": []
              },
              {
                "id": "175",
                "parent": "173",
                "text": "* PD avanzada: ↓dosis, ↑frecuencia (si coexiste \"wearing off\").",
                "guid": "kKxiK_5w-H0N5EgtZbgbxQ",
                "children": []
              },
              {
                "id": "176",
                "parent": "173",
                "text": "* CR: No útil, inicio retardado, biodisponibilidad/absorción impredecibles.",
                "guid": "xOoCGUAffCMqffGarsU5Xg",
                "children": []
              },
              {
                "id": "177",
                "parent": "173",
                "text": "* ↓/eliminar: Agonistas dopamina, ICOMT, IMAO, istradefyllina.",
                "guid": "xAO-0GD0XUAxXbLw8vbjGw",
                "children": []
              },
              {
                "id": "178",
                "parent": "173",
                "text": "* Paradójico: Agonista dopamina dosis baja (rotigotina transdérmica, pramipexol/ropinirol ER)\n→ ↓dyskinesia, ↓\"wearing off\".",
                "guid": "Iw9_mqJvBscCFM6BFof-cA",
                "children": []
              }
            ]
          },
          {
            "id": "179",
            "parent": "163",
            "text": "* Amantadina:",
            "guid": "R39VxDDbIMdaFasZrLn0NA",
            "children": [
              {
                "id": "180",
                "parent": "179",
                "text": "* Útil en PD avanzada con tx optimizado.",
                "guid": "m0xAC9TDYxidRlRgER0q_g",
                "children": []
              },
              {
                "id": "181",
                "parent": "179",
                "text": "* Dosis:",
                "guid": "iVJnAgDQXJQjLJsgsax9fA",
                "children": [
                  {
                    "id": "182",
                    "parent": "181",
                    "text": "* IR: 100 mg/día, ↑100 mg 2 veces/día, máx. 400 mg/día.",
                    "guid": "muoTjGbe5JS8cC_I6VxjUA",
                    "children": []
                  },
                  {
                    "id": "183",
                    "parent": "181",
                    "text": "* ER: 1 vez/día, no + eficaz, + caro.",
                    "guid": "qc2WeFJnRgGpi3p_wcqajA",
                    "children": []
                  }
                ]
              },
              {
                "id": "184",
                "parent": "179",
                "text": "* Efectos 2arios: Edema periférico, livedo reticularis, estreñimiento, visión borrosa, retención urinaria, pesadillas.",
                "guid": "Qn9a--XNCBZbKZQgzgsthQ",
                "children": []
              },
              {
                "id": "185",
                "parent": "179",
                "text": "* Alucinaciones, confusión, delirio, psicosis: En >80 años o con deterioro cognitivo.",
                "guid": "zI0OzPWwkvI5UiUPEkCrTg",
                "children": []
              },
              {
                "id": "186",
                "parent": "179",
                "text": "* Excreción renal: ↓dosis si ClCr <50 mL/min.",
                "guid": "LIAfixNCcfJJjKlacpzjdQ",
                "children": []
              },
              {
                "id": "187",
                "parent": "179",
                "text": "* Eficacia:",
                "guid": "iDkLuE4phbrW_0Eu2mQ1QQ",
                "children": [
                  {
                    "id": "188",
                    "parent": "187",
                    "text": "* IR: ↓puntuaciones dyskinesia 25-50% vs. placebo, efecto sostenido >1 año.",
                    "guid": "q9rEpAuOtSODXFRcAYw0EQ",
                    "children": []
                  },
                  {
                    "id": "189",
                    "parent": "187",
                    "text": "* ER: ↓duración/severidad/impacto dyskinesia, ↑\"off\" ~0.9h.",
                    "guid": "ukIFw2eZS5kboyRZFjxcTA",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "190",
            "parent": "163",
            "text": "* Clozapina:",
            "guid": "bv3-m2dqN3z0vw07vmrt1g",
            "children": [
              {
                "id": "191",
                "parent": "190",
                "text": "* Dyskinesia/psicosis refractarias, intolerancia a otras estrategias.",
                "guid": "ZR41tH9NXaZLFAZII5RC_Q",
                "children": []
              },
              {
                "id": "192",
                "parent": "190",
                "text": "* Monitorización neurológica/psiquiátrica.",
                "guid": "IZ1fRibjXP38P4CsXrjLrg",
                "children": []
              },
              {
                "id": "193",
                "parent": "190",
                "text": "* Dosis baja (30-50 mg/día): ↓dyskinesia.",
                "guid": "lJktQzssLF0DLzu63n8Icw",
                "children": []
              },
              {
                "id": "194",
                "parent": "190",
                "text": "* Limitación: Riesgo agranulocitosis.",
                "guid": "HXVSvZ5WgdFu7hOSFIpjWA",
                "children": []
              },
              {
                "id": "195",
                "parent": "190",
                "text": "* REMS: Monitorización leucocitos/neutrófilos.",
                "guid": "0DOrhkCfTjN_ZccFvocZTw",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "196",
        "parent": "0",
        "text": "VII. Resolución de Complicaciones\nMotoras Complejas en PD",
        "guid": "",
        "children": [
          {
            "id": "197",
            "parent": "196",
            "text": "* Periodos \"off\"\nimpredecibles:",
            "guid": "hI1iDcqo2qkYrXJqKiJWww",
            "children": [
              {
                "id": "198",
                "parent": "197",
                "text": "* Transiciones \"on\" → \"off\" repentinas, no relacionadas con dosis levodopa.",
                "guid": "g10eHHAnN5YxroQarW_9SA",
                "children": []
              },
              {
                "id": "199",
                "parent": "197",
                "text": "* PD avanzada, con otras fluctuaciones/dyskinesia grave.",
                "guid": "n3HHngHyVRQI9AmilgiJmg",
                "children": []
              },
              {
                "id": "200",
                "parent": "197",
                "text": "* Causas: Absorción errática levodopa, cambios receptores.",
                "guid": "tgQrv5K8GR3Kv0abSxh5lg",
                "children": []
              },
              {
                "id": "201",
                "parent": "197",
                "text": "* Estrategias:",
                "guid": "97ZEBwrO1AcHMruwPizjmQ",
                "children": [
                  {
                    "id": "202",
                    "parent": "201",
                    "text": "* Educación: Interacción proteínas-levodopa.",
                    "guid": "YVecM76TJ054G3vJWyrOUA",
                    "children": []
                  },
                  {
                    "id": "203",
                    "parent": "201",
                    "text": "* Horario medicación: Pauta regular, comidas en horario, evitar CR.",
                    "guid": "iHTP4uYyl71U3QQ-wIPMhA",
                    "children": []
                  },
                  {
                    "id": "204",
                    "parent": "201",
                    "text": "* Diarios/observación: Documentar episodios, descartar \"wearing off\", diferenciar de FOG.",
                    "guid": "a6X765WxiVFb3m4BfISQ2Q",
                    "children": []
                  },
                  {
                    "id": "205",
                    "parent": "201",
                    "text": "* Ajustes dosis: ↓dosis levodopa, añadir adyuvante (agonista dopamina, IMAO, istradefyllina, amantadina, ICOMT).",
                    "guid": "6SRZPE_pGz6lbrYocZdpHw",
                    "children": []
                  },
                  {
                    "id": "206",
                    "parent": "201",
                    "text": "* Terapias rescate: Apomorfina SC/SL, levodopa inhalada.",
                    "guid": "fIE8pLu8si068xyZPD1bYA",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "207",
            "parent": "196",
            "text": "* Bloqueo de la\nmarcha (FOG):",
            "guid": "F_D9rMEgsb_aseqbK_hxmA",
            "children": [
              {
                "id": "208",
                "parent": "207",
                "text": "* \"Off\" transitorio (responde a levodopa) / aleatorio en \"on\" (relacionado con levodopa).",
                "guid": "drru2HLjoqrNOXfcXAjJTQ",
                "children": []
              },
              {
                "id": "209",
                "parent": "207",
                "text": "* FOG sensible a levodopa:",
                "guid": "E03YXC_ghH8JYhLcqDX24g",
                "children": []
              },
              {
                "id": "210",
                "parent": "207",
                "text": "* Durante \"off\", responde a ↓intervalo/↑dosis levodopa.",
                "guid": "R_ohz2XQE-VKHEMQUHMmSw",
                "children": []
              },
              {
                "id": "211",
                "parent": "207",
                "text": "* Posible: Medicación adyuvante (poca evidencia).",
                "guid": "fv0CO2RrowdQyb4oL-30mA",
                "children": []
              },
              {
                "id": "212",
                "parent": "207",
                "text": "* DBS: Si FOG \"off\" con otras fluctuaciones DBS-responsivas.",
                "guid": "5P-XFomxyN65W2BpiFD1jg",
                "children": []
              },
              {
                "id": "213",
                "parent": "207",
                "text": "* FOG en \"on\":",
                "guid": "di3uEHEwjzxbsSctkDYVtQ",
                "children": []
              },
              {
                "id": "214",
                "parent": "207",
                "text": "\\\\/* Posible: ↓dosis agonista dopamina / ↓dosis levodopa\n(riesgo: ↓\\\\/ Respuesta levodopa para otros síntomas).",
                "guid": "I8Yz2FXQ5445TCDPgrbjpw",
                "children": []
              },
              {
                "id": "215",
                "parent": "207",
                "text": "* Poco frecuente (5%), duración < FOG sensible a levodopa.",
                "guid": "tFJyLtSCCJ_vysyrz3r_ZA",
                "children": []
              },
              {
                "id": "216",
                "parent": "207",
                "text": "* Manejo FOG grave:",
                "guid": "EKjjTbjhoAiKCMZxsH5FfQ",
                "children": [
                  {
                    "id": "217",
                    "parent": "216",
                    "text": "* Fisioterapia, manejo comorbilidades.",
                    "guid": "eqdRVjcApJcD8dX_wa3GMQ",
                    "children": []
                  },
                  {
                    "id": "218",
                    "parent": "216",
                    "text": "* Estrategias movimiento: Desplazar peso, giros amplios, pasos largos, imágenes visuales.",
                    "guid": "C1fx-zkpUm7F7cS9fGj7Yw",
                    "children": []
                  },
                  {
                    "id": "219",
                    "parent": "216",
                    "text": "* Bastón (normal/láser).",
                    "guid": "QL6LZGGsR8PRGUiTH3bmlw",
                    "children": []
                  },
                  {
                    "id": "220",
                    "parent": "216",
                    "text": "* Metilfenidato: Datos contradictorios.",
                    "guid": "67cehaUAEvaLZsuX7Df2mg",
                    "children": []
                  },
                  {
                    "id": "221",
                    "parent": "216",
                    "text": "* Amantadina: Posible efecto beneficioso.",
                    "guid": "cNEMI6L2kCyIQ4211n3iJg",
                    "children": []
                  }
                ]
              },
              {
                "id": "222",
                "parent": "207",
                "text": "* DBS convencional: Ineficaz para FOG.",
                "guid": "rrRN4XkBudJw2ZlsL2WgQQ",
                "children": []
              },
              {
                "id": "223",
                "parent": "207",
                "text": "* Alternativas DBS: Estimulación núcleo pedunculopontino (PPTN), ↓frecuencia (60 Hz).",
                "guid": "mmwoRYfIqEGl3awYC9gpLQ",
                "children": []
              },
              {
                "id": "224",
                "parent": "207",
                "text": "* Estimulación periférica: Estimulación médula espinal implantable, dispositivos robóticos externos.",
                "guid": "ExAmDJ4s6kjCpO1w0bTNTQ",
                "children": []
              }
            ]
          },
          {
            "id": "225",
            "parent": "196",
            "text": "* Fallo\nrespuesta \"on\":",
            "guid": "VjInzmYje7wW0vA53AxW5A",
            "children": [
              {
                "id": "226",
                "parent": "225",
                "text": "* \"On\" retardado/fallo/\"no-on\".",
                "guid": "uQq7XINudgCzWgbz_WdlRA",
                "children": [
                  {
                    "id": "227",
                    "parent": "226",
                    "text": "* Causas: ↓absorción (vaciado gástrico), \"off\" prolongado (receptores estriatales).",
                    "guid": "oduXj_t0XrLt9_rq5mtpZg",
                    "children": []
                  },
                  {
                    "id": "228",
                    "parent": "226",
                    "text": "* Estrategias:",
                    "guid": "mnYZFAgdSYKgcnEVPv0muw",
                    "children": [
                      {
                        "id": "229",
                        "parent": "228",
                        "text": "* Evitar proteínas con medicación, levodopa con estómago vacío, PRD.",
                        "guid": "0PTAUPs8-JHv_hgJUQzPIQ",
                        "children": []
                      },
                      {
                        "id": "230",
                        "parent": "228",
                        "text": "* Evaluar gastroparesia/estreñimiento: Test tránsito gastrointestinal.",
                        "guid": "HVNhibJMOC_tHiUZhZz64w",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "231",
                    "parent": "226",
                    "text": "* Tx gastroparesia:",
                    "guid": "AtPmDnt2k0qxvQikrO9GEw",
                    "children": [
                      {
                        "id": "232",
                        "parent": "231",
                        "text": "* Metoclopramida: Contraindicada (bloquea receptores dopamina).",
                        "guid": "LCbIhueq26wg1Gt80vcp7g",
                        "children": []
                      },
                      {
                        "id": "233",
                        "parent": "231",
                        "text": "* Domperidona: Bloqueador dopamina periférico, no disponible en EEUU, riesgo QT prolongado/arritmias.",
                        "guid": "2HHAuGwLzehD65MPcm5Gsg",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "234",
                "parent": "225",
                "text": "* ↓episodios \"off\".",
                "guid": "wZWFG99EvOeBRZdRVJzX3Q",
                "children": [
                  {
                    "id": "235",
                    "parent": "234",
                    "text": "* Ajustar horario levodopa: Añadir dosis 1h antes de fallo \"on\" predecible.",
                    "guid": "6-DMkS4gOOc-woZmqQUYQg",
                    "children": []
                  },
                  {
                    "id": "236",
                    "parent": "234",
                    "text": "* Terapias rescate: Apomorfina SC/SL, levodopa inhalada.",
                    "guid": "oYzif9HnEsIVOTQCVpBYsA",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "237",
            "parent": "196",
            "text": "* Akinesia\naguda:",
            "guid": "sAyifIAC_TENc0KDqFbR4g",
            "children": [
              {
                "id": "238",
                "parent": "237",
                "text": "* Exacerbación PD, estado akinético, dura días, ↓respuesta a medicación.",
                "guid": "o3DKO3aH8WBXOajGSdtjIw",
                "children": []
              },
              {
                "id": "239",
                "parent": "237",
                "text": "* ≠ \"wearing off\" / \"off\" impredecible, puede ocurrir sin levodopa.",
                "guid": "d1ACBTCQ47VzEVnYpjB9Zw",
                "children": []
              },
              {
                "id": "240",
                "parent": "237",
                "text": "* Causas: Infección, problemas médicos, error medicación.",
                "guid": "zoeBXbPPME_JpPtZmL00zg",
                "children": []
              },
              {
                "id": "241",
                "parent": "237",
                "text": "* Situación emergencia: Hospitalización, investigación, tx soporte.",
                "guid": "dyQKrx8UxdTHyjAhLQFNLg",
                "children": []
              }
            ]
          },
          {
            "id": "242",
            "parent": "196",
            "text": "* Distonía:",
            "guid": "WcOZcKC5xA0qgWQ_WnO23Q",
            "children": [
              {
                "id": "243",
                "parent": "242",
                "text": "* Contracciones musculares: Movimientos/posturas anormales.",
                "guid": "sqOn3nykFqVx81PNTMwouQ",
                "children": []
              },
              {
                "id": "244",
                "parent": "242",
                "text": "* PD temprana sin tx / complicación levodopa.",
                "guid": "v823j56hfqEjikjhMjEyAg",
                "children": []
              },
              {
                "id": "245",
                "parent": "242",
                "text": "* Distonía por levodopa: Efecto pico / \"off\" (retirada).",
                "guid": "AdSzJi466dO6zBH5HZJR2w",
                "children": []
              }
            ]
          },
          {
            "id": "246",
            "parent": "196",
            "text": "* Distonía \"off\":",
            "guid": "x1tiKsYn-HJmvwaTsu3K7Q",
            "children": [
              {
                "id": "247",
                "parent": "246",
                "text": "* Matutina: CR al acostarse, levodopa/agonista dopamina por la noche/mañana, rescate (apomorfina).",
                "guid": "hg_xnNNOJ9nTETRgW0M21A",
                "children": []
              },
              {
                "id": "248",
                "parent": "246",
                "text": "* Diurna: Manejo similar a \"wearing off\".",
                "guid": "aQmxQE8j39tyHjb5rDH4zw",
                "children": []
              },
              {
                "id": "249",
                "parent": "246",
                "text": "* Distonía pico de dosis: Manejo similar a dyskinesia pico de dosis.",
                "guid": "I4AEfbiWokngiMw7NDlJLg",
                "children": []
              },
              {
                "id": "250",
                "parent": "246",
                "text": "* Distonía craneal/facial: Sospechar parkinsonismo atípico.",
                "guid": "r3_X8QkzcS--BmVx4ZbpRw",
                "children": []
              }
            ]
          },
          {
            "id": "251",
            "parent": "196",
            "text": "* Akatisia:",
            "guid": "14ZDuWl0bDV2EE-wChXfyg",
            "children": [
              {
                "id": "252",
                "parent": "251",
                "text": "* Inquietud motora, tipo síndrome piernas inquietas, nocturno.",
                "guid": "iFMbaOFl_KPqU_tr_WPllQ",
                "children": []
              },
              {
                "id": "253",
                "parent": "251",
                "text": "* Manejo: CR al acostarse, agonista dopamina.",
                "guid": "VPBY0FIcSQdlanbkoBTiYQ",
                "children": []
              },
              {
                "id": "254",
                "parent": "251",
                "text": "* Algunos pacientes: Síndrome piernas inquietas real.",
                "guid": "dF2KVyeUdNJsNtNw7KZ4pA",
                "children": []
              }
            ]
          },
          {
            "id": "255",
            "parent": "196",
            "text": "* Dyskinesia\nbifásica:",
            "guid": "Hh_m-uFIxfeRmAkXM9GhmQ",
            "children": [
              {
                "id": "256",
                "parent": "255",
                "text": "* Picos dyskinesia: \"On\" / \"off\".",
                "guid": "eeHtAl2J-XqHgK32HCkXjw",
                "children": []
              },
              {
                "id": "257",
                "parent": "255",
                "text": "* 2ª fase: Dyskinesia (movimientos gran amplitud en piernas) + signos parkinsonianos (temblor, bradikinesia).",
                "guid": "d61j7dXwdR_oXBDScu0lYw",
                "children": []
              },
              {
                "id": "258",
                "parent": "255",
                "text": "* Manejo:",
                "guid": "7YC7bLehRv1nWKub7aU0sw",
                "children": [
                  {
                    "id": "259",
                    "parent": "258",
                    "text": "* ↑frecuencia levodopa (riesgo: ↑dyskinesia pico de dosis, dyskinesia nocturna).",
                    "guid": "aNY9Gg8k71atfsXWW5JMiw",
                    "children": []
                  },
                  {
                    "id": "260",
                    "parent": "258",
                    "text": "* Posible: Añadir agonista dopamina, ↓dosis levodopa.",
                    "guid": "M31BuUSq4jr_xhwHNEgtTw",
                    "children": []
                  },
                  {
                    "id": "261",
                    "parent": "258",
                    "text": "* Evitar CR.",
                    "guid": "ElSk30Y3jz7aPTTK3nCuPg",
                    "children": []
                  },
                  {
                    "id": "262",
                    "parent": "258",
                    "text": "* Considerar: LCIG, DBS, CSAI (monitorizar con LCIG).",
                    "guid": "RnHMe6WxNEagFwYNgQwNvw",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      }
    ]
  },
  "node_count": 263,
  "relations": [],
  "cross_references": [],
  "specialty": "Neurología",
  "folder": "- Entidades clínicas/Neurología",
  "filename": "UTD. E. Parkinson. Manejo de diskinesia y fluctuaciones motoras-2025-1",
  "id": "map_1598",
  "resolved_references": [],
  "related_maps": [
    {
      "id": "map_1649",
      "title": "Enfermedad de Parkinson Dic 2024"
    },
    {
      "id": "map_1650",
      "title": "Parkinsonismo"
    },
    {
      "id": "map_1868",
      "title": "E. Parkinson. Manejo de\\Ndiskinesia y fluctuaciones motoras"
    },
    {
      "id": "map_1894",
      "title": "Enfermedad de Parkinson\\NDic 2024"
    }
  ]
}